cannabinoids

Atlas Biotechnologies to Fund Research into Cannabis Treatment for MS, Similar Diseases

Atlas BiotechnologiesĀ will fund and provide support to three research projects at the University of AlbertaĀ to possibly identify cannabis component(s) that could help people with neurological diseases likeĀ multiple sclerosis (MS). The cannabis plant produces hundreds of biological compounds, the best-known being tetrahydrocannabinol (THC) ā€” the psychoactive compound primarily…

MMJ Enters Agreement to Produce Cannabis-based Capsules for Clinical Trials in MS and Huntingtonā€™s

MMJ International HoldingsĀ announced that it has entered into an agreement for the production of its proprietary cannabis-based gel capsule ā€” a product mix of tetrahydrocannabinol (THC) and cannabidiol (CBD) ā€” in compliance with guidelines set by the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA).

Axim Improves Delivery of Cannabinoids in Chewing Gums

Axim Biotechnologies announced that it has succeeded in microencapsulating cannabinoids (chemical compounds in cannabis) into the companyā€™s patented chewing gums, which are used to treat several disease symptoms, including pain and spasticity associated withĀ multiple sclerosis (MS). Since the active cannabinoids are degradable in the body, the company needed…

Top 10 Multiple Sclerosis Stories of 2018

Multiple Sclerosis News Today brought you daily coverage of key findings, treatment developments, andĀ clinical trials related to multiple sclerosis (MS) throughout 2018. We look forward to reporting more news to patients, family members, and caregivers dealing with MS during 2019. Here are the top 10 most-read articles of…

Sativex Can Improve Driving Ability of MS Patients, Study Says

Sativex, a cannabis-based anti-spasticity medicine commercialized as oromucosal spray by GW Pharmaceuticals, improves the driving ability of patients with multiple sclerosis (MS), according to researchers. The findings were published in the journal Brain and Behavior, in a study titled ā€œThe influence of THC:CBD oromucosal spray…

MMJ Files US Patent for Multiple Sclerosis Cannabinoid Treatment

MMJ International Holdings has applied to the U.S. Patent and Trademark Office (USPTO) for new pharmaceutical compounds and methods to treat and prevent symptoms associated with multiple sclerosis (MS) and other diseases responsive to cannabinoids. The patent covers MMJ BioScienceā€™s intellectual property portfolio, which comprises several patent families…

MMJ Hires Lead Investigator for Phase 2 Trials of Medicinal Cannabis to Treat Progressive MS

MMJ BioScience, an affiliate of medical cannabis research company MMJ International Holdings, has hired a principal investigator to lead clinical trials exploring potential therapeutic applications of cannabinoids inĀ progressive multiple sclerosis (MS). Dr. Bianca Weinstock-Guttman, a neurology professor at the State University of New York at Buffalo,Ā is executive director…

Brazil Allows HempMeds to Import RSHO Cannabidiol for MS Treatment

The Brazilian government has authorizedĀ HempMeds Brasil, a unit of California-basedĀ Medical Marijuana, to import the parent company’sĀ hemp cannabidiol (CBD) oil flagship product ā€” known as Real Scientific Hemp Oil (RSHO) ā€”Ā for the management of multiple sclerosis (MS) symptoms. This is the first time Brazil’s National Health Surveillance Agency…

95% of MS Patients Open to Marijuana Treatment, 73% Have Tried It

Ninety-five percent ofĀ multiple sclerosis (MS)Ā patients believe medical marijuana should be a treatment option, according to aĀ GeneFoĀ online survey. The survey also showed that almost 73 percent had tried it, even though about half said they hadn’t received information from a doctor about its benefits and risks. A National…

Cannabis Compounds Ease Spasticity in MS, National Academies’ Report States

CertainĀ cannabinoids reduce spasticity symptoms inĀ multiple sclerosis (MS) patients, according toĀ aĀ reportĀ  from the National Academies of Sciences, Engineering, and MedicineĀ thatĀ scrutinized published research about the benefits and hazards of cannabis and cannabinoid use. Cannabinoids also show proven effectĀ in other areas that may be importantĀ to MS patients, but they are linked…